Metastasi linfonodali in pazienti affetti da sarcoma delle parti molli delle estremità

Title

Code

MetaLinf

Type

Osservazionale

Start Year

2024

Status

In Corso

Principal Investigator

051-6366511

luca.cevolani@ior.it

Cevolani Luca, MD

3rd Orthopaedic and Traumatologic Clinic prevalently Oncologic

Operational unit that carry out the study

complex unit

Clinica Ortopedica e Traumatologica III a prevalente indirizzo Oncologico

Director

Donati Davide Maria, MD

Go to the details >>

Documents and Videos attachament

Attachment

Nulla osta alla conduzione dello studio prot. MetaLinf

Thursday 11 April 2024, 12:16

PG0005711_2024_Stampa_unica.pdf

You might also be interested in

Clinical Trial

A Phase 2/3, Randomized, Multicenter Study to Evaluate AL102 in Patients with Progressing Desmoid Tumors

Clinical Trial

Phase study 1/2 to evaluate palbociclib (IBRANCE®) in combination with irinotecan and temozolomide or in combination with topotecan and cyclophosphamide in pediatric patients with recurrent orrefractory solid tumors

Sito Web Istituto Ortopedico Rizzoli

DIPARTIMENTO RIZZOLI-SICILIA

Metastasi linfonodali in pazienti affetti da sarcoma delle parti molli delle estremità

Principal Investigator

Operational unit that carry out the study

Documents and Videos attachament

You might also be interested in